What's inside Elon's building in Memphis will shock you
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Shares Stats
| Shares Outstanding | 5,685,000,000 |
| Shares Float | 5,675,900,000 |
| Shares Short | 99,270,000 |
| Insider Holdings | 6% |
| Institution Holdings | 67.50% |
About Pfizer Inc
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
General
| Name | Pfizer Inc |
| Ticker | PFE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 81,000 |
Highlights
| Analyst Target | 28.32 |
| Market Cap | 133,549,200,000 |
| PE Ratio | 17.02 |
| PEG Ratio | 0.74 |
| EBITDA | 23,320,999,936 |
Financials
| Curr Year EPS Estimate | 3.01 |
| Next Quarter EPS Estimate | 0.57 |
| Profit Margin | 12.59% |
| Operating Margin | 27.53 |
| Return on Assets | 0.05 |
| Return on Equity | 0.09 |
| Revenue | 62.5B |
| Earnings Per Share | 1.38 |
| Revenue Per Share | 11.02 |
| Gross Profit | 46,487,998,464 |
| Quarterly Revenue Growth | -0.08 |
Valuation
| Trailing PE | 16.88 |
| Forward PE | 7.97 |
| Price/Sales (Trailing 12 Mt.) | 2.12 |
| Price/Book (Most Recent Quarter) | 1.47 |
Dividend
Pfizer Inc pays out a dividend of $1.70 per share, with a dividend yield of 7.25%.
PFE's next dividend payment will be made to shareholders on September 2, 2025.
They pay out 119.94% of their earnings out as a dividend.
Recent Dividends
| Sep 2, 2025 | $0.43 |
| Jun 13, 2025 | $0.43 |
| Mar 7, 2025 | $0.43 |
| Dec 2, 2024 | $0.42 |
| Sep 3, 2024 | $0.42 |
| Jun 14, 2024 | $0.42 |
| Mar 1, 2024 | $0.42 |
| Dec 4, 2023 | $0.41 |
Jim Cramer Recommends This 'Really, Really Good' Energy Stock
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
Cathie Wood Doubles Down On Tesla Despite Leadership Exodus, Dumps $22 Million Of Crypto Stocks Amid Bitcoin Buzz
Cathie Wood-led Ark Invest made significant trades on Tuesday, involving major companies like Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Colbert jokes about 'cancel culture' and has a very pointed message for President Donald Trump
Stephen Colbert returned for his first full program after that CBS was canceling his “Late Show” with some supportive late-night guests, a joke about cancel culture and an extremely pointed remark directed at President Donald Trump.
Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs
On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Stakin
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Donald Trump Files $10 Billion Lawsuit Against WSJ And Rupert Murdoch
Donald Trump has filed a $10 billion defamation lawsuit against The Wall Street Journal and Rupert Murdoch.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Trump Diagnosed With Chronic Venous Insufficiency, A Common Circulatory Condition In Over-70s, White House Says He's 'In Excellent Health'
The White House revealed President Trump is diagnosed with chronic health condition.
The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008
A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
How Trump could use a building renovation to oust the Fed chair
WASHINGTON (AP) — President says he has finally found a way to achieve his goal of removing Federal Reserve Chair Jerome Powell, accusing him of mismanaging the U.S. central bank’s $2.5 billion renovation project.
Trump-Backed DOJ Motion Seeks Release Of Jeffrey Epstein, Maxwell Grand Jury Transcripts
DOJ moves to unseal grand jury testimony related to Jeffrey Epstein and Ghislaine Maxwell following criticism over handling of documents.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
MP Materials, Nvidia, AMD, Alibaba And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major indices were mixed on Tuesday with the Dow Jones Industrial Average falling nearly 1% to 44,023.29.
What's in the Republican bill cutting $9 billion from public broadcasting and foreign aid
WASHINGTON (AP) — The Republican-led Congress is testing the popularity of spending cuts this week by aiming to pass President Donald Trump’s request to in public broadcasting and foreign aid spending.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant
Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.
Microsoft Q4 Preview: Can The Tech Giant Beat Forecasts For 10th Straight Quarter?
Microsoft has beaten revenue and earnings per share estimates from analysts in the last nine straight quarters. Investors look for another beat and strength in AI and cloud.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
BlackSky Technology Stock Tumbled On Tuesday: What Happened?
BlackSky Technology Inc. (NYSE: BKSY) shares fell nearly 10% on Tuesday after Canaccord Genuity cut its price target on the stock.
Feihe Struggles Amid China's Dairy Oversupply And Falling Birth Rates
Declining birth rates and China's slowing economy are taking a toll on the company and its peers as they grapple with oversupply and asset impairments on excess inventory
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Trump's 'Happy Crypto Week' Gets Off To Rocky Start As House Suspends Votes On Key Bills
The House of Representatives called off Tuesday’s votes on pivotal cryptocurrency bills, citing a procedural failure.
Samsung Inks Decade-Long $16.5 Billion Chip Manufacturing Pact With Mystery Tech Giant As It Fights To Regain Ground From TSMC
Samsung has secured a $16.5 billion chipmaking deal with a mystery global client, boosting its foundry ambitions amid stiff AI competition and looming U.S. tariff risks.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
It’s moo-ving day for dairy cattle at Michigan State University
EAST LANSING, Mich. (AP) — Dozens of dairy cattle were on the moo-ve Monday at Michigan State University.
XRP Falls Nearly 2.5% As Ripple Co-Founder Transfers $150 Million Worth Of Coins From Wallet — Analyst Says, 'He's Dumping On You'
A wallet tied to Ripple co-founder and executive chairman Chris Larsen transferred out hundreds of millions worth of XRP (CRYPTO: XRP) over the last week.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
Jack Dorsey's Block, With Over $1 Billion In Bitcoin Holdings, Set To Join S&P 500 — Shares Pop 8% In Overnight Trading
Block, Inc. (NYSE:XYZ) shares are soaring in overnight trading on Sunday ahead of the S&P 500 debut of the Jack Dorsey-founded fintech company.
AI Hallucinations Persist Because Models Can't Access Real-Time, Verifiable Data, Says Nuklai Founder
Amid growing concerns over AI-generated misinformation and hallucinated outputs, Matthijs de Vries, founder of data infrastructure firm Nuklai, argues that better model architecture alone is insufficient. Speaking with Benzinga, de Vries said the deeper issue lies in fragmented and unreliable access to real-time, verifiable data.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Senate committee advances Trump nominee to lead cybersecurity agency that protects election systems
NEW YORK (AP) — A U.S. Senate committee voted Wednesday to advance President Donald Trump’s pick to lead the agency that secures the nation’s critical infrastructure, .
Palestinian death toll surpasses 60,000 in the Israel-Hamas war, Gaza’s Health Ministry says
DEIR AL-BALAH, Gaza Strip (AP) — More than 60,000 Palestinians have been killed during the Israel-Hamas war, Gaza’s Health Ministry said Tuesday. Israeli strikes overnight killed more than two dozen people, mostly women and children, according to health officials.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Trump Says Not 'Necessary' To Fire Jerome Powell — But Presses Fed Chair On Rate Cuts And $2.5 Billion Renovation: 'I'd Love Him To Lower Interest Rates'
In a rare Presidential visit to the Federal Reserve headquarters, President Donald Trump publicly pressed Fed Chair Jerome Powell to deliver sharp interest rate cuts while criticizing the central bank's $2.5 billion renovation project.
Elon Musk's xAI Plans To Raise $12 Billion In Debt To Buy Nvidia Chips And Build One Of The World's Largest AI Superclusters: Report
Elon Musk's xAI is reportedly seeking $12 billion in debt financing to buy Nvidia chips and build a massive AI supercluster, signaling an aggressive push to stay competitive in the global AI arms race.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks
HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by year-end.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.